Jeffrey S Mathiesen Panbela Therapeutics, Inc. (PBLA) insider trading activity

Jeffrey S Mathiesen is Director of Panbela Therapeutics, Inc.. Currently has a direct ownership of 10,191 shares of PBLA, which is worth approximately $3,668. The most recent transaction as insider was on May 25, 2021, when has been sold 4,316 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 10.2K

0% 3M change

0% 12M change

Total Value Held $3,668

JEFFREY S MATHIESEN Transaction History

Date	Transaction	Value	Shares Traded	Shares Held	Form
May 25 2021	BUY Grant, award, or other acquisition	-	4,316 Added 29.75%	10,191 Common Stock
Dec 01 2020	BUY Grant, award, or other acquisition	-	2,875 Added 32.86%	5,875 Common Stock

Also insider at

HSDT

HELIUS MEDICAL TECHNOLOGIES, INC. Healthcare

CFO and Treasurer

NMTC

NEUROONE MEDICAL TECHNOLOGIES Corp Healthcare

JSM